Evidence map›Paper›PMID 36233794›Full record

ReviewJournal of clinical medicine2022

Neuromodulation Applied to Diseases: The Case of HRV Biofeedback.

Asaf Gitler, Leen Vanacker, Marijke De Couck, Inge De Leeuw, Yoram Gidron

Open access · goldAbstract readReview
In one paragraph

Review in Journal of clinical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
6.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 40 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Asaf GitlerFaculty of Social Welfare and Health Sciences, Department of Nursing, University of Haifa, Haifa 3498838, Israel.ORCID 0000-0002-7198-1972
Leen VanackerFaculty of Medicine and Pharmacy, Department of Public Health, Mental Health and Wellbeing Research Group, Free University of Brussels (VUB), 1140 Evere, Belgium.
Marijke De CouckFaculty of Medicine and Pharmacy, Department of Public Health, Mental Health and Wellbeing Research Group, Free University of Brussels (VUB), 1140 Evere, Belgium.
Inge De LeeuwFaculty of Medicine and Pharmacy, Department of Public Health, Mental Health and Wellbeing Research Group, Free University of Brussels (VUB), 1140 Evere, Belgium.
Yoram GidronFaculty of Social Welfare and Health Sciences, Department of Nursing, University of Haifa, Haifa 3498838, Israel.
University of Haifa · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The vagus or "wandering" nerve is the main branch of the parasympathetic nervous system (PNS), innervating most internal organs crucial for health. Activity of the vagus nerve can be non-invasively indexed by heart-rate variability parameters (HRV). Specific HRV parameters predict less all-cause mortality, lower risk of and better prognosis after myocardial infarctions, and better survival in cancer. A non-invasive manner for self-activating the vagus is achieved by performing a slow-paced breathing technique while receiving visual feedback of one's HRV, called HRV-biofeedback (HRV-B). This article narratively reviews the biological mechanisms underlying the role of vagal activity and vagally mediated HRV in hypertension, diabetes, coronary heart disease (CHD), cancer, pain, and dementia. After searching the literature for HRV-B intervention studies in each condition, we report the effects of HRV-B on clinical outcomes in these health conditions, while evaluating the methodological quality of these studies. Generally, the levels of evidence for the benefits of HRV-B is high in CHD, pain, and hypertension, moderate in cancer, and poor in diabetes and dementia. Limitations and future research directions are discussed.

Indexed as

biofeedbackcancerclinical outcomescoronary heart diseaseheart-rate-variability (HRV)hypertensionpainvagally mediated HRV (vmHRV)vagus nerve

Identifiers

PMID36233794
PMCPMC9571900
OpenAlexW4303709752

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.